Ignite Creation Date:
2024-05-06 @ 11:13 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03466073
Status:
COMPLETED
Last Update Posted:
2020-01-27
First Post:
2018-03-02
Brief Title:
A Phase 1b2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP
Sponsor:
BioAegis Therapeutics Inc
Organization:
BioAegis Therapeutics Inc
Organization Data
Organization:
BioAegis Therapeutics Inc
Class:
INDUSTRY
Study ID:
BTI-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioAegis Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None